Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
about
Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E ProteinPathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveDengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeysProgress in the identification of dengue virus entry/fusion inhibitorsRecognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particlesMechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.Human monoclonal single-chain antibodies specific to dengue virus envelope protein.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteinsBasic amino acid residues of human eosinophil derived neurotoxin essential for glycosaminoglycan binding.Antiviral drug discovery: broad-spectrum drugs from nature.Receptors and routes of dengue virus entry into the host cells.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model.Riboflavin and ultraviolet light: impact on dengue virus infectivity.Characterization of in vitro dengue virus resistance to carrageenan.Molecular basis of antibody-mediated neutralization and protection against flavivirus.Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry.Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.Peptides as Therapeutic Agents for Dengue Virus.Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.Zika Virus Structure, Maturation, and Receptors.Flavivirus Receptors: Diversity, Identity, and Cell EntryEarly Events in Japanese Encephalitis Virus Infection: Viral Entry
P2860
Q26700124-1C1E11FD-FE16-4837-9B87-A97E8479103FQ29994529-2ADDC95C-2E39-413B-8066-C10DFA9F8AF4Q33800244-BA1C77BF-1FFE-4933-8E4F-3CC3D98DE8A9Q34054616-91429582-5BB8-4E39-B4E5-4C3837192B99Q34093421-6D0EA7A1-FE93-49D6-8D90-3CD03F208EA4Q34306877-0F5132D7-3199-44D9-A667-1C88E62AFDEDQ34354665-B88FD762-1A33-46B6-B01B-AB52BE5B6603Q34408025-546FC044-37BE-4C3C-ACFD-C5982FB7A72EQ34981768-B97E98E8-8960-4471-82D7-2BEA72B194CDQ35050826-CD153E31-E2F7-4E1D-809A-31F15B4D5C33Q35138111-DAD635D0-CD5F-4C90-B7EA-AB2D26E964D8Q37225263-48D2C839-451A-4292-9A53-66C49E4EC3CDQ38260235-8A355A3D-0755-4ECD-90D9-491FD51AC63EQ38366005-4A4B6354-9DEA-41A1-9C0E-BE8120A7B977Q38636217-B4F53AD4-E8F8-4256-86BD-E06E01BFF0CAQ38730891-42ECFA5B-7ACD-4C23-BFF4-2DE8A9A549BAQ38808618-DC900153-F4FE-4210-B860-1001BDF39AE5Q38809813-2633032B-BB24-4110-B709-DF164CA2F1F6Q38948606-FB1DE4AD-3A74-4E74-B3A6-54F8E6B6C91AQ40175804-1C27A6F3-EB8B-49E1-BAD7-3A730EDEDBB7Q42730622-7F502DDE-AD8F-45D4-A149-A84D13E04E6AQ45323856-8A111059-D882-40BB-A07F-1652A5DE739AQ46261471-4CE74C67-80D6-4A57-A71C-E6CEFDE9C8FBQ47558310-FB9FCEBF-0838-469C-BDFF-1F5B6A2F72AEQ57491430-FA3DDEAF-20F2-475F-8F9B-5B250CF25E0EQ58784010-90AFB8A7-61CC-4E1C-A1B1-D7AA10722E25
P2860
Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Residues in domain III of the ...... ace glycosaminoglycan binding.
@en
type
label
Residues in domain III of the ...... ace glycosaminoglycan binding.
@en
prefLabel
Residues in domain III of the ...... ace glycosaminoglycan binding.
@en
P50
P356
P1476
Residues in domain III of the ...... ace glycosaminoglycan binding.
@en
P356
10.1099/VIR.0.037317-0
P407
P577
2011-09-28T00:00:00Z